Omer Dizdar (Ömer Dizdar)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Radiation Induced

Metastatic Colorectal Cancer

Top Venues

Expert review of anticancer therapy

South Asian journal of cancer

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Gürkan Güner, Levent Ozcakar, Yusuf Baytar, Mehmet Ruhi Onur, Metin Demir, Burak Yasin Aktaş, Oktay Halit Aktepe, Deniz Can Guven, Hakan Taban, Hasan Cagrı Yıldırım, Serkan Akın, Sercan Aksoy, Murat Kara, Omer Dizdar
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy. Cancers 16 (5) (2024)
Gürkan Güner, Levent Ozcakar, Yusuf Baytar, Mehmet Ruhi Onur, Metin Demir, Burak Yasin Aktaş, Oktay Halit Aktepe, Deniz Can Guven, Hakan Taban, Hasan Cagrı Yıldırım, Serkan Akın, Sercan Aksoy, Murat Kara, Omer Dizdar
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy. Cancers 16 (5) (2024)
Nesime İnci Güner, Omer Dizdar, Alev Türker, Aygin Bayraktar Ekincioğlu
Rituximab-induced leukocytoclastic vasculitis in a patient with low-grade orbital B-cell lymphoma: a case report. Anti-cancer drugs (2024)
Deniz Can Guven, Hasan Cagrı Yıldırım, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktaş, Suayib Yalcin, Omer Dizdar
Emerging treatment strategies in hepatobiliary cancer. Expert review of anticancer therapy 23 (3) (2023)
Deniz Can Guven, Hasan Cagrı Yıldırım, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktaş, Suayib Yalcin, Omer Dizdar
Emerging treatment strategies in hepatobiliary cancer. Expert review of anticancer therapy (2023)
Deniz Can Guven, Hasan Cagrı Yıldırım, Fatih Kus, Enes Erul, Neyran Kertmen, Omer Dizdar, Sercan Aksoy
Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment. Expert review of anticancer therapy (2023)
Deniz Can Guven, Hasan Cagrı Yıldırım, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktaş, Suayib Yalcin, Omer Dizdar
Emerging treatment strategies in hepatobiliary cancer. Expert review of anticancer therapy 23 (3) (2023)
Deniz Can Guven, Hasan Cagrı Yıldırım, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktaş, Suayib Yalcin, Omer Dizdar
Emerging treatment strategies in hepatobiliary cancer. Expert review of anticancer therapy 23 (3) (2023)
Emine Duran, Zeynep Ozge Ozturk, Abdulsamet Erden, Yahya Buyukasik, Omer Dizdar, Gözde Kübra Yardimci, Bayram Farisoğulları, Zehra Özsoy, Gizem Ayan, Güllü Sandal Uzun, Mustafa Ekici, Erdinc Unaldi, Levent Kilic, Ali Akdoğan, Ömer Karadağ, Şaziye Şule Apraş Bilgen, Sedat Kiraz, Umut Kalyoncu, Ali Ihsan Ertenli
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry. Rheumatology and therapy (2023)
Burak Yasin Aktaş, Emine Büşra Ata, Engin Çeşmeci, İbrahim Yahya Çakır, Muharrem Coşkunpınar, Yağmur Tahillioğlu, Gürkan Güner, Deniz Can Güven, Zafer Arık, Neyran Kertmen, Omer Dizdar, Şuayib Yalçın, Sercan Aksoy
Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia. Current oncology (Toronto, Ont.) 30 (11) (2023)
Deniz Can Guven, Hasan Cagrı Yıldırım, Elvin Chalabiyev, Fatih Kus, Feride Yilmaz, Serkan Yasar, Arif Akyildiz, Burak Yasin Aktaş, Suayib Yalcin, Omer Dizdar
Emerging treatment strategies in hepatobiliary cancer. Expert review of anticancer therapy (2023)
Metin Demir, Deniz Can Guven, Burak Yasin Aktaş, Gurkan Guner, Oktay Halit Aktepe, Hakan Taban, Yusuf Karakas, Saadettin Kılıçkap, Ayşe Kars, Alev Türker, Omer Dizdar
Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience. South Asian journal of cancer 11 (4) (2022)
Metin Demir, Deniz Can Guven, Burak Yasin Aktaş, Gurkan Guner, Oktay Halit Aktepe, Hakan Taban, Yusuf Karakas, Saadettin Kılıçkap, Ayşe Kars, Alev Türker, Omer Dizdar
Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience. South Asian journal of cancer 11 (4) (2022)
Deniz Can Guven, Oktay Halit Aktepe, Hakan Taban, Burak Yasin Aktaş, Gurkan Guner, Hasan C Yildirim, Taha Koray Sahin, Melek S Aksun, Omer Dizdar, Sercan Aksoy, Mustafa Erman, Şuayib Yalçin, Saadettin Kılıçkap
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors. Biomarkers in medicine 15 (13) (2021)
Omer Dizdar
Comments on "Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database". International journal of cancer 148 (4) (2020)
Deniz Can Guven, Omer Dizdar, Abdullah Cevdet Akman, Ezel Berker, Emre Yekedüz, Furkan Ceylan, Batuhan Başpinar, İlgın Akbıyık, Burak Yasin Aktaş, Deniz Yuce, Mustafa Erman, Mutlu Kadir Hayran
Evaluation of cancer risk in patients with periodontal diseases Turkish journal of medical sciences 49 (3) (2019)
Emre Bilgin, Omer Dizdar, Deniz Can Guven, Serdar Ceylan, Özge Aybi, Busra Firlatan, Rıza Can Kardaş, Tolga Yıldırım, Mutlu Kadir Hayran, Umut Kalyoncu, Seher Sener
Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia. Rheumatology international 39 (6) (2019)